229 related articles for article (PubMed ID: 35795204)
1. A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas.
Liu B; Liu Z; Feng C; Tu C
Front Genet; 2022; 13():899545. PubMed ID: 35795204
[No Abstract] [Full Text] [Related]
2. Necroptosis-related lncRNA-based novel signature to predict the prognosis and immune landscape in soft tissue sarcomas.
Long Q; Li Z; Yang W; Huang K; Du G
J Cancer Res Clin Oncol; 2024 Apr; 150(4):203. PubMed ID: 38635069
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients.
Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B
Front Genet; 2022; 13():966896. PubMed ID: 36186456
[No Abstract] [Full Text] [Related]
4. Construction of a necroptosis-related lncRNA signature for predicting prognosis and revealing the immune microenvironment in bladder cancer.
Wang J; Jiang Z; Wang K; Zheng Q; Jian J; Liu X; Chen Z; Yang R; Wang L
Aging (Albany NY); 2024 Feb; 16(3):2812-2827. PubMed ID: 38319718
[TBL] [Abstract][Full Text] [Related]
5. Construction of a Novel Signature and Prediction of the Immune Landscape in Soft Tissue Sarcomas Based on N6-Methylandenosine-Related LncRNAs.
Zhang L; Tang X; Wan J; Zhang X; Zheng T; Lin Z; Liu T
Front Mol Biosci; 2021; 8():715764. PubMed ID: 34733885
[No Abstract] [Full Text] [Related]
6. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.
Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y
J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma.
Liu B; Pang K; Feng C; Liu Z; Li C; Zhang H; Liu P; Li Z; He S; Tu C
Front Genet; 2022; 13():1063057. PubMed ID: 36568384
[No Abstract] [Full Text] [Related]
8. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
Front Genet; 2022; 13():862741. PubMed ID: 35368663
[No Abstract] [Full Text] [Related]
9. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer.
Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H
Front Genet; 2022; 13():938250. PubMed ID: 36561319
[No Abstract] [Full Text] [Related]
10. A Novel Necroptosis-Related lncRNA Signature for Osteosarcoma.
Zheng Y; Xu J; Lin J; Lin Y
Comput Math Methods Med; 2022; 2022():8003525. PubMed ID: 35844445
[TBL] [Abstract][Full Text] [Related]
11. Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer.
Liu Y; Hao H; Kang L; Zheng G; Guo X; Li B; Zhao H; Hao H
BMC Gastroenterol; 2022 Jul; 22(1):345. PubMed ID: 35840890
[TBL] [Abstract][Full Text] [Related]
12. Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinoma.
Zhang R; Li Q; Yu X; Hou Y; Yan L; Gao Y; Ji L; Zhang X; Fang M; Huang L; Yu Z; Gao Y; Li M
Heliyon; 2023 Nov; 9(11):e22083. PubMed ID: 38034714
[TBL] [Abstract][Full Text] [Related]
13. A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer.
Luo J; Peng J; Xiao W; Huang S; Cao Y; Wang T; Wang X
Front Genet; 2022; 13():984696. PubMed ID: 36092933
[No Abstract] [Full Text] [Related]
14. A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer.
Yu Z; Lu B; Gao H; Liang R
J Oncol; 2022; 2022():5643496. PubMed ID: 36425941
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma.
Lin Z; Pang K; Li H; Zhang X; Wan J; Zheng T; Liu T; Peng W
Front Cell Dev Biol; 2021; 9():709241. PubMed ID: 34631703
[No Abstract] [Full Text] [Related]
16. Construction and experimental validation of a necroptosis-related lncRNA signature as a prognostic model and immune-landscape predictor for lung adenocarcinoma.
Zhang T; Hei R; Huang Y; Shao J; Zhang M; Feng K; Qian W; Li S; Jin F; Chen Y
Am J Cancer Res; 2023; 13(9):4418-4433. PubMed ID: 37818057
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis of necroptosis‑related lncRNAs and immune infiltration, and prediction of the prognosis of patients with esophageal carcinoma.
Duan X; Du H; Yuan M; Liu L; Liu R; Shi J
Exp Ther Med; 2023 Jul; 26(1):331. PubMed ID: 37346407
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs.
Wang G; Zhang X; Feng W; Wang J
Front Genet; 2022; 13():917935. PubMed ID: 35692813
[No Abstract] [Full Text] [Related]
19. A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity.
Liu B; Feng C; Liu Z; Tu C; Li Z
Front Pharmacol; 2022; 13():944158. PubMed ID: 36105232
[No Abstract] [Full Text] [Related]
20. A novel marker based on necroptosis-related long non-coding RNA for forecasting prognostic in patients with clear cell renal cell carcinoma.
Lv J; Xu Q; Wu G; Hou J; Yang G; Tang C; Qu G; Xu Y
Front Genet; 2022; 13():948254. PubMed ID: 36212132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
